-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, V9F9pFgSOpKn9N3zJjgjGS14gV4BVXsHof62VkFeQx6KE5rURw+jVHD72UPoxVhS LHw7eqevwOMvdUTogSG8Ug== 0000929638-09-001282.txt : 20090731 0000929638-09-001282.hdr.sgml : 20090731 20090731162503 ACCESSION NUMBER: 0000929638-09-001282 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090723 FILED AS OF DATE: 20090731 DATE AS OF CHANGE: 20090731 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908 541 8671 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 STREET 2: ATT: GENERAL COUNSEL CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: IRIDIAN ASSET MANAGEMENT LLC/CT CENTRAL INDEX KEY: 0001033427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 09977651 BUSINESS ADDRESS: STREET 1: 276 POST RD WEST CITY: WESTPORT STATE: CT ZIP: 06880-4704 BUSINESS PHONE: 2033417800 MAIL ADDRESS: STREET 1: 276 POST ROAD WEST CITY: WESTPORT STATE: CT ZIP: 06880-4704 3 1 frm3iridianassetmgmt31jul_ex.xml X0203 3 2009-07-23 1 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001033427 IRIDIAN ASSET MANAGEMENT LLC/CT 276 POST ROAD WEST WESTPORT CT 06880-4704 0 0 1 0 The reporting person may be deemed to be a beneficial owner of common stock of Enzon Pharmaceuticals, Inc. ("Common Stock") for purposes of Section 16, but is not reporting any ownership of Common Stock because the reporting person has no pecuniary interest in such shares. /s/ Harold J. Levy, Co-President 2009-07-31 -----END PRIVACY-ENHANCED MESSAGE-----